Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
-
Narrated by:
-
By:
About this listen
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet